Skip to main content

Apple Cider Vinegar Beneficial for Overweight, Obese Individuals

Medically reviewed by Carmen Pope, BPharm. Last updated on March 13, 2024.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, March 13, 2024 -- For overweight and obese individuals, apple cider vinegar (ACV) consumption is associated with a significant reduction in anthropometric variables, as well as improvement in blood glucose triglyceride and cholesterol levels, according to a study published online March 12 in BMJ Nutrition, Prevention & Health.

Rony Abou-Khalil, Ph.D., from the Holy Spirit University of Kaslik in Jounieh, Lebanon, and colleagues examined the effects of ACV consumption on weight and blood glucose, triglyceride, and cholesterol levels in 120 individuals of the Lebanese population with overweight and obesity. Participants were randomly assigned to an intervention group receiving 5, 10, or 15 mL of ACV or a control group receiving a placebo during a 12-week period. At weeks 0, 4, 8, and 12, measurements of anthropometric parameters, fasting blood glucose, and triglyceride and cholesterol levels were taken.

The researchers observed associations for daily consumption of the three doses of ACV for four to 12 weeks with significant reductions in anthropometric variables (weight, body mass index, waist/hip circumferences, and body fat ratio), blood glucose, and triglyceride and cholesterol levels. During the 12 weeks of ACV intake, there were no significant risk factors observed.

"These results suggest that ACV might have potential benefits in improving metabolic parameters related to obesity and metabolic disorders in obese individuals," the authors write. "The results may contribute to evidence-based recommendations for the use of ACV as a dietary intervention in the management of obesity."

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted March 2024

Read this next

Text Messages + Financial Incentives Boost Weight Loss at 12 Months

WEDNESDAY, May 15, 2024 -- Among men with obesity, an intervention with text messaging plus financial incentive significantly improves weight loss compared with a control group...

GLP-1 Receptor Agonist Use Increases Likelihood of Antidepressant Prescription

WEDNESDAY, May 15, 2024 -- Individuals taking glucagon-like peptide (GLP)-1 receptor agonists have a greater risk for subsequently being dispensed antidepressants, according to a...

Four in 10 Adults With Diabetes Report Taking a GLP-1 Receptor Agonist

TUESDAY, May 14, 2024 -- One in eight adults (12 percent) say they have ever taken a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and 6 percent say they are currently using...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.